Literature DB >> 24312787

Development of a dispersive liquid-liquid microextraction technique for the extraction and spectrofluorimetric determination of fluoxetine in pharmaceutical formulations and human urine.

Ahad Bavili Tabrizi1, Ahmad Rezazadeh.   

Abstract

PURPOSE: Fluoxetine is the most prescribed antidepressant drug worldwide. In this work, a new dispersive liquid-liquid microextraction (DLLME) method combined with spectrofluorimetry has been developed for the extraction and determination of FLX in pharmaceutical formulations and human urine.
METHODS: For FLX determination, the pH of a 10 mL of sample solution containing FLX, was adjusted to 11.0. Then, 800 µL of ethanol containing 100 µL of chloroform was injected rapidly into the sample solution. A cloudy solution was formed and FLX extracted into the fine droplets of chloroform. After centrifugation, the extraction solvent was sedimented and supernatant aqueous phase was readily decanted. The remained organic phase was diluted with ethanol and its fluorescence was measured at 292±3 nm after excitation at 234±3 nm.
RESULTS: Some important parameters influencing microextraction efficiency were investigated. Under the optimum extraction conditions, a linear calibration curve in the range of 10 to 800 ng/mL with a correlation coefficient of r(2) = 0.9993 was obtained. Limit of detection (LOD) and limit of quantification (LOQ) were found to be 2.78 and 9.28 ng/mL, respectively. The relative standard deviations (RSDs) were less than 4%. Average recoveries for spiked samples were 93-104%.
CONCLUSION: The proposed method gives a very rapid, simple, sensitive, wide dynamic range and low-cost procedure for the determination of FLX.

Entities:  

Keywords:  Dispersive liquid–liquid microextraction; Fluoxetine; Injectable formulation; Spectrofluorimetry; Urine

Year:  2012        PMID: 24312787      PMCID: PMC3845995          DOI: 10.5681/apb.2012.024

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  26 in total

1.  Investigation and analytical application of the reactions of eriochrome cyanine R with fluvoxamine and fluoxetine.

Authors:  B Starczewska; H Puzanowska-Tarasiewicz; K Baranowska
Journal:  J Pharm Biomed Anal       Date:  2000-08-15       Impact factor: 3.935

2.  Rapid methods for determination of fluoxetine in pharmaceutical formulations.

Authors:  R Mandrioli; V Pucci; D Visini; G Varani; M A Raggi
Journal:  J Pharm Biomed Anal       Date:  2002-08-01       Impact factor: 3.935

3.  Assay validation for three antidepressants in pharmaceutical formulations: practical approach using capillary gas chromatography.

Authors:  J J Berzas Nevado; M J Villaseñor Llerena; A M Contento Salcedo; E Aguas Nuevo
Journal:  J Pharm Biomed Anal       Date:  2005-06-01       Impact factor: 3.935

4.  Cyclodextrin enhanced spectrofluorimetric determination of fluoxetine in pharmaceuticals and biological fluids.

Authors:  J J Berzas; A Alañón; J A Lázaro
Journal:  Talanta       Date:  2002-08-23       Impact factor: 6.057

5.  Liquid chromatographic-mass spectrometric method for the determination of fluoxetine and norfluoxetine in human plasma: application to clinical study.

Authors:  S Djordjevic; I Kovacevic; B Miljkovic; J Vuksanovic; M Pokrajac
Journal:  Farmaco       Date:  2005-04

6.  Development of a dispersive liquid-liquid microextraction method for iron speciation and determination in different water samples.

Authors:  Ahad Bavili Tabrizi
Journal:  J Hazard Mater       Date:  2010-08-24       Impact factor: 10.588

7.  Development and validation of spectrophotometric methods for determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms.

Authors:  Ibrahim A Darwish
Journal:  J AOAC Int       Date:  2005 Jan-Feb       Impact factor: 1.913

8.  Quality assessment of fluoxetine and fluvoxamine pharmaceutical formulations purchased in different countries or via the Internet by 19F and 2D DOSY 1H NMR.

Authors:  Saleh Trefi; Véronique Gilard; Stéphane Balayssac; Myriam Malet-Martino; Robert Martino
Journal:  J Pharm Biomed Anal       Date:  2007-12-04       Impact factor: 3.935

9.  Liquid chromatographic determination of fluoxetine.

Authors:  Mohamed A El-dawy; Mokhtar M Mabrouk; Fawzy A El-Barbary
Journal:  J Pharm Biomed Anal       Date:  2002-10-15       Impact factor: 3.935

10.  Three-phase, liquid-phase microextraction combined with high performance liquid chromatography-fluorescence detection for the simultaneous determination of fluoxetine and norfluoxetine in human plasma.

Authors:  Daniela Fernanda de Freitas; Carlos Eduardo Dobrovolskin Porto; Elisabeth Pizzamiglio Vieira; Maria Elisa Pereira Bastos de Siqueira
Journal:  J Pharm Biomed Anal       Date:  2009-07-19       Impact factor: 3.935

View more
  1 in total

1.  Analysis of piroxicam in pharmaceutical formulation and human urine by dispersive liquid-liquid microextraction combined with spectrophotometry.

Authors:  Ahad Bavili Tabrizi; Nakisa Seyyedeh Tutunchi
Journal:  Adv Pharm Bull       Date:  2013-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.